Pre-B ALL with thymic involvement in CD19+/CreSfpi1lox/loxSpib−/− mice. (A) Kaplan-Meier survival plot for aging mice of the indicated genotype and sex. (B) Enlarged thymus (arrow), enlarged spleen, and enlarged liver are shown in a moribund CD19+/CreSfpi1lox/loxSpib−/− mouse. (C) Histology of the thymus in a moribund CD19+/CreSfpi1lox/loxSpib−/− mouse (original magnification ×4). (D) Enlargement of thymic section shown in panel C, original magnification ×60. (E) Histology of the liver in moribund CD19+/CreSfpi1lox/loxSpib−/− mice. (F) Enlargement of liver section shown in panel E to demonstrate the presence of lymphocytes in sinusoids, original magnification ×60. (G) High frequency of immature B cells in the thymus of a moribund CD19+/CreSfpi1lox/loxSpib−/− mouse. Flow cytometric analysis was performed to determine the frequency of cells expressing the indicated cell surface markers in the thymus of a moribund CD19+/CreSfpi1lox/loxSpib−/− mouse. (H) Measurement of Sfpi1lox allele frequencies in thymic pre-B cells. qPCR was performed to determine the relative frequency of intact Sfpi1lox alleles in pre-B cells from the thymus of a moribund CD19+/CreSfpi1lox/loxSpib−/− mouse (right bar). As a control, the Sfpi1lox allele frequency in splenic B cells enriched from an 8-week-old CD19+/+Sfpi1lox/loxSpib−/− mice was determined and set to 1.00 (left bar). qPCR also was performed on C57Bl/6 B cell genomic DNA (center bar) as an additional negative control to demonstrate specificity of the qPCR reaction.